Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market
Holding TRDA?
Track your performance easily

Entrada Therapeutics Inc (TRDA) Financial Statements

72 Followers

Entrada Therapeutics Inc Financial Overview

Entrada Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $2.958; its P/E ratio is 4.96; Entrada Therapeutics Inc is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 94.69M$ 59.12M$ 41.85M$ 43.73M$ 18.17M
Gross Profit$ 94.69M$ 59.12M$ 41.85M$ 43.73M$ 18.17M
EBIT$ 57.83M$ 21.11M$ 4.91M$ 36.13M$ -12.08M
EBITDA$ 60.77M$ 22.05M$ 5.64M$ 35.07M$ -12.97M
Net Income Common Stockholders$ 55.03M$ 23.50M$ -9.54M$ 53.53M$ -25.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 185.25M$ 68.44M$ 67.60M$ 51.88M$ 79.74M
Total Assets$ 581.96M$ 510.84M$ 469.19M$ 485.03M$ 493.98M
Total Debt$ 64.44M$ 66.43M$ 68.23M$ 69.07M$ 73.03M
Net Debt$ -120.81M$ -2.00M$ 628.00K$ 17.19M$ -6.71M
Total Liabilities$ 152.04M$ 241.48M$ 226.83M$ 238.37M$ 287.07M
Stockholders Equity$ 429.93M$ 269.37M$ 242.36M$ 246.66M$ 206.90M
Cash Flow-
Free Cash Flow$ 38.79M$ -26.36M$ -4.99M$ -25.94M$ -36.54M
Operating Cash Flow$ 39.83M$ -25.52M$ -4.01M$ -24.49M$ -35.02M
Investing Cash Flow$ -24.38M$ 26.15M$ 19.04M$ -3.74M$ -113.26M
Financing Cash Flow$ 101.37M$ 206.00K$ 690.00K$ 368.00K$ 443.00K
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

Entrada Therapeutics Inc Debt to Assets

Entrada Therapeutics Inc Cash Flow

Entrada Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis